Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 EUR | +1.76% | +2.06% | +55.02% |
Apr. 16 | Finland’s Nightingale Health Plots US Expansion | MT |
Apr. 16 | Nightingale Health to Establish A Laboratory in the United States | CI |
Sales 2024 * | 4.7M 5.1M | Sales 2025 * | 8.7M 9.44M | Capitalization | 104M 113M |
---|---|---|---|---|---|
Net income 2024 * | -16M -17.35M | Net income 2025 * | -16M -17.35M | EV / Sales 2024 * | 8.19 x |
Net cash position 2024 * | 65.9M 71.47M | Net cash position 2025 * | 52.2M 56.61M | EV / Sales 2025 * | 6 x |
P/E ratio 2024 * |
-6.41
x | P/E ratio 2025 * |
-6.41
x | Employees | 81 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.93% |
Latest transcript on Nightingale Health Oyj
1 day | +1.76% | ||
1 week | +2.06% | ||
1 month | -3.35% | ||
3 months | +57.85% | ||
6 months | +49.14% | ||
Current year | +55.02% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Würtz
FOU | Founder | - | 01-12-31 |
Satu Saksman
FOU | Founder | 48 | 01-12-31 |
Pasi Soininen
FOU | Founder | - | 01-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-12-16 | |
Chairman | 61 | 20-12-31 | |
Olli Pekka Karhi
BRD | Director/Board Member | 61 | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.73 | +1.76% | 28,396 |
24-05-30 | 1.7 | -.--% | 38,694 |
24-05-29 | 1.7 | +2.10% | 30,794 |
24-05-28 | 1.665 | -0.89% | 34,087 |
24-05-27 | 1.68 | -0.88% | 58,087 |
Delayed Quote Nasdaq Helsinki, May 31, 2024 at 11:17 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.02% | 113M | |
-9.49% | 28.16B | |
+25.35% | 8.33B | |
+33.25% | 4.39B | |
-35.85% | 2.43B | |
-9.44% | 1.6B | |
-13.39% | 1.5B | |
-32.84% | 1.15B | |
+7.80% | 964M | |
-37.56% | 872M |
- Stock Market
- Equities
- HEALTH Stock